![]() |
|
|
|||||||
|
|
LinkBack | Thread Tools | Display Modes |
|
|||
|
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced results of a randomized study comparing ZEVALIN injection for intravenous use plus high-dose BEAM chemotherapy vs.
|
| Thread Tools | |
| Display Modes | |
|
|